Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Neonatal Database
Neonatal Database Download
Neonatal Journal Abstracts
Feedback
Salient Features
Open Access
Editorial Board
Publisher
Publication Ethics & Malpractice
Journal Policy
Peer Review Process
Contact Us
Current Issue
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
IJNMR Performance
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here
Register For Article Submission
Login Here
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJARS
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Original article / research

Year :2021 Month : April Volume : 9 Issue : 2 Page : PO01 - PO05 Full Version

Role of Procalcitonin and C-Reactive Protein in the Early Diagnosis of Neonatal Sepsis


Sumedha Yadav, Mumtaz Sharif, Amit Saxena, Shital Kolhe, Divyani Dhole
1. Resident, Department of Paediatrics, D Y Patil University, Navi Mumbai, Maharashtra, India. 2. Professor, Department of Paediatrics, D Y Patil University, Navi Mumbai, Maharashtra, India. 3. Associate Professor, Department of Paediatrics, D Y Patil University, Navi Mumbai, Maharashtra, India. 4. Associate Professor, Department of Paediatrics, D Y Patil University, Navi Mumbai, Maharashtra, India. 5. Resident, Department of Paediatrics, D Y Patil University, Navi Mumbai, Maharashtra, India.
 
Correspondence Address :
Dr. Shital Kolhe,
601, Mangal Prabha, Sec 9, Nerul, Navi Mumbai-400706, Maharashtra, India.
E-mail: kolhe.nelson@gmail.com
 
ABSTRACT

: Introduction: Neonatal Sepsis (NS) is responsible for 30-50% of total neonatal deaths in developing countries. Blood culture is gold standard diagnostic test but has a low yield and is the time consuming. C-Reactive Protein (CRP) and Procalcitonin (PCT) are commonly used for diagnosis of sepsis.

Aim: To study the role of CRP and PCT in the screening of NS and to compare PCT and CRP in relation to sensitivity, specificity and accuracy.

Materials and Methods: A cross-sectional study was conducted in a tertiary care Neonatal Intensive Care Unit (NICU) from February 2018 and November 2019. Neonates with signs and symptoms of sepsis or born to mothers with risk factors for sepsis were included. Those who received antibiotic before admission or had co-morbidities such as meconium aspiration, birth asphyxia, etc., were excluded. Investigations for sepsis including Complete Blood Count (CBC), CRP, PCT and Blood Culture were done. They were classified into three groups as group 1 clinical sepsis, group 2 suspected sepsis and group 3 confirmed sepsis. The statistical test used was Analysis of Variance (ANOVA) test and tests for sensitivity, specificity, positive predictive value, negative predictive value were also used.

Results: The sensitivity, specificity, PPV, and NPV of CRP and PCT versus culture report were evaluated. The sensitivity was 61.90% and 90.47%, specificity was 72.45% and 82.75%, PPV was 61.90% and 79.16% and NPV was 72.45% and 92.30% for CRP and PCT, respectively. The accuracy of the test was 68.00% and 86.00% for CRP and PCT, respectively.

Conclusion: PCT is a better septic marker than CRP in relation to sensitivity, specificity and accuracy and correlates positively with blood culture.
Keywords : Blood culture, Infection, Inflammatory markers, Newborn, Septic screen
DOI and Others : 10.7860/IJNMR/2021/48641.2295

Date of Submission: Jan 22, 2021
Date of Peer Review: Feb 16, 2021
Date of Acceptance: Mar 16, 2021
Date of Publishing: Jun 01, 2021

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes (from parents)
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHE
 
INTRODUCTION

Neonatal Sepsis is a common cause of mortality and morbidity throughout the world. In the developing countries alone, it is responsible for about 30-50% of the total neonatal deaths (1),(2). NS is a clinical syndrome which is characterised by signs and symptoms of infection with or without accompanying bacteremia within the first 28 days of life (3). Signs of sepsis are generally non-specific and subtle like decreased activity, refusal to feed, temperature instability, etc., and do not distinguish among aetiological organisms, whether bacterial and viral. In conjunction to clinical signs and symptoms, the investigations which can be used for diagnosis of NS includes blood culture, total leucocyte count and differential count; an immature-to-total neutrophil ratio, neutropenia; thrombocytopenia; acute phase reactants like levels of CRP, PCT, haptoglobulin, fibrinogen, and cytokines (4),(5).

Early diagnosis of sepsis is required for timely initiation of treatment and reducing the mortality. Blood culture, though the gold standard test, is time-consuming. Unnecessary antibiotic administration may cause problems of antibiotic resistance and its related complications. Hence, other markers of sepsis with the optimum sensitivity, reliability, and positive predictability, are required for early diagnosis and management of NS. Among these markers, CRP and PCT are most commonly used for diagnosis and follow-up. CRP level begins to rise after six hours of infection and peaks at 24 to 48 hours and then, decline as the inflammation decreases and PCT which is also an acute phase reactant rises as early as four hours after infection or exposure to bacterial toxins, peaks at 6-8 hours and correlates to the severity of illness. But CRP though cost-effective can also get elevated in non-infectious condition such as meconium aspiration syndrome/birth asphyxia and they can affect the specificity of the test. PCT values are not affected by such non-clinical conditions but can get affected by viral infection (6).

There are various studies in western literature but only few studies are available in Indian literature that compares CRP and PCT with exclusion of confounding factors (7),(8). With this background, this study was conducted with an objective to assess the role of CRP and PCT in the screening of NS and to compare PCT and CRP in relation to sensitivity, specificity and accuracy after exclusion of confounding factors.
 
 
Material and Methods

This cross-sectional study was conducted in the neonatology unit in the tertiary teaching institute in DY Patil Hospital, Navi Mumbai, Maharashtra, India between February 2018 and November 2019. Ethics committee approval was taken prior to commencing the study (Ref No. PDDYPMC/Ethics/PG Dissert/2018). Informed consent of the parents was taken before recruiting into the study.

Inclusion criteria

• Newborn infants <28 days of life with signs and symptoms of NS (breathing problems, respiratory distress, apnea, tachycardia, bradycardia, hypotension, delayed Capillary Refilling Time (CRT), feeding intolerance, abdominal distension, Gastrointestinal (GI) bleed, diarrhoea, vomiting, jaundice, reduced movements, reduced sucking, seizures, hypothermia, hyperthermia, hypoglycaemia, hyperglycaemia, petechial rash, purpura, mottling, sclerema).

• Any neonate born to with maternal risk factors for sepsis, e.g., Prolonged Preterm Rupture of Membrane (PROM) >18 hours, maternal intrapartum pyrexia, urinary tract infection, prolonged labour, or chorioamnionitis were included.

Exclusion criteria

• Neonates who were on antibiotics prior to admission and those who developed the signs of sepsis within 72 hours of discontinuation of the antibiotics.
• Neonates with other co-morbidities such as meconium aspiration, birth asphyxia, hyaline membrane disease, laboratory findings which were suggestive of or confirmed for the inborn errors of metabolism and congenital anomalies and infants of diabetic mothers were excluded.

Newborns meeting inclusion criteria were then divided into three groups based on the following criteria. Criteria Employed for defining sepsis group (7),(8),(9).

Group 1 (Clinical sepsis)

• Clinical signs suggestive of sepsis are present.

• Atleast one parameter for sepsis screen positive. Total Leukocyte Count (TLC) >24,000/cubic millimetre (cumm) or less than 5,000/cumm, Absolute Neutrophil Count (ANC) <1800/mm, Platelets <1,50,000 mcL, CRP more than 6mg/L, PCT level of ≥0.5 ng/mL).

• Negative Blood culture.

Group 2 (Suspected sepsis)

• Clinical signs suggestive of sepsis are present.
• At least two parameters for sepsis screen positive.
• Blood culture negative.

Group 3 (Confirmed sepsis)
• Clinical signs suggestive of sepsis are present.
• At least two parameters for sepsis screen positive.
• Blood culture positive.

The blood specimen was obtained from each neonate before the commencement of antibiotics. The septic workup included haematological parameters like TLC, the ANC, platelet count, blood culture and antibiotic sensitivity, PCT and CRP estimation. Serum CRP level was measured by using the A-15 CRP Kit. The quantitative measurement of CRP from the serum was done by a nephelometric method in the laboratory according to the manufacturer’s instructions. The serum PCT level was measured by using the Chemiluminescence Immunoassay (CLIA) method on Maglumi1000. A PCT level of ≥0.5 ng/mL and CRP more than 6 mg/L is considered as pathological.

STATISTICAL ANALYSIS

The statistical analysis was done using ANOVA test and diagnostic tests (for sensitivity, specificity, PPV, NPV) and the software used was Statistical Package for Social Sciences (SPSS) Version 24.0 (IBM Corporation, Chicago, USA).
 
 
Results

Out of 50 neonates, Group 1 had 21 cases (42%), Group 2 had 8 cases (16%), and group 3 had 21cases (42%). The mean age was 6.76 days, gestational age was 36.22 weeks, and birth weight was 1995.24 grams. There was a slight male preponderance (58%) in the study population. Overall, prematurity was seen in 66% (33 cases). (Table/Fig 1) shows demographic distribution. The mean gestational age and mean birth weight was significantly low in group 3.

(Table/Fig 2) shows comparison of maternal risk factor in various groups and PROM was seen more in group 3 but statistically not significant. (Table/Fig 3) shows distribution of signs and symptoms of NS. Most common symptom was feeding intolerance. (Table/Fig 4) shows distribution of hemoglobin, leucocytes and platelets. Anemia was seen more in group 3 but statistically not significant. Thrombocytopenia was more in group 3 and was statistically significant.


The (Table/Fig 5) shows distribution of organism isolated from blood culture. Most common organisms isolated was Klebsiella pneumoniae. (Table/Fig 6) shows distribution of mean CRP and PCT in various groups. (Table/Fig 7) shows comparison of PCT and CRP in terms of sensitivity, specificity, PPV, NPV and accuracy. There were eight deaths in total, all of which were in Group 3. It was also seen that the mean PCT level was high in these cases (Table/Fig 8).
 
 
Discussion

In this study, the two most commonly used markers of sepsis, i.e., CRP and PCT, which are used alone or in combination were compared. Clinical profile and risk factor for NS were also analysed.

Fifty neonates were divided on the basis of clinical features and laboratory parameters into three groups. It was observed that most of them (90%) were Low Birth Weight (LBW) babies, and 66% were preterms suggesting prematurity and LBW as important risk factors for NS. Similar results are seen by Bala Y et al., where 84.6% were LBW and 79.3% were preterms. A study by Ghosh P et al., reported 75% LBW (10),(11). Premature newborns have immature skin and mucous membrane and underdeveloped defense mechanism against infection; hence they have a greater risk of developing sepsis. There was slight male preponderance though statistically insignificant. Similar study by Park IH et al., highlights male preponderance (12).

Amongst the maternal risk factors, majority (38%) had PROM and the maximum of these babies were culture positive though statistically not significant. Maternal Urinary Tract Infection (UTI) was seen in 8% and one case of chorioamnionitis. Studies done by Jafar H et al., and by Kumar R et al., identified PROM >24 hours, prolonged labour and maternal fever as the predominant risk factor (13),(14).

Amongst the clinical features, 68% had feeding intolerance almost half had features suggestive of shock. Other clinical features like tachycardia, hyperthermia, seizures, lethargy, irritability, sclerema were also noted. Various studies have depicted the similar clinical spectrum (7),(8),(15) which are the established clinical features of sepsis. Anaemia was more in the confirmed sepsis group though statistically insignificant. Thrombocytopenia was significantly more in the confirmed sepsis group, especially with Klebsiella sepsis. Most common bacterial organisms isolated were Klebsiella followed by E.coli, Staphylococcus and Enterobacter. Culture positivity was found to be inversely related to birth weight and gestational age.

The mean CRP of subjects with confirmed sepsis was higher compared to clinical and suspected sepsis group and the difference was statistically significant. The sensitivity of CRP for proven sepsis was 61.90%, its specificity was 72.45%, PPV was 61.90%, and its NPV was 72.45% sepsis. The accuracy of this test was 68%.
According to various studies, the sensitivity of CRP ranged from as low as 28% to as high as 100% while specificity ranged from 69.7% to 100% (9),(16). These wide ranges can be due to different sample sizes, cut-off values, analytical tests and methodologies, characteristics of cases, the difference in exclusion and inclusion criteria, and different sampling timing. In a study by Thyai S and Ramesh TV, the sensitivity, specificity, PPV, NPV and CRP accuracy were 66.66%, 76.19%, 54.54%, 84.21% and 62.3%, respectively which were quite similar to present study (7). While Jaffar H et al., reported the sensitivity, specificity, PPV, NPV and accuracy as 79.7%, 50.7%, 41.6%, 85%, respectively (13). These two studies had similar inclusion and exclusion criteria as this study. CRP level begins to rise after six hours of infection and peaks at 24 to 48 hours and then decline as the inflammation decreases. However, it can rise in a non-infectious condition also and does not differentiate between bacterial and viral infection (17).

In this study, PCT was positive in almost half the cases. There was a difference in PCT levels between confirmed sepsis cases and suspected and clinical cases which were statistically significant. The sensitivity, specificity, PPV, NPV and accuracy were 90.47%, 82.75%, 79.16, 92.30 and 86.00%, respectively. In various studies, PCT sensitivity in the early diagnosis of NS was 80-100% while the specificity was 70-100% (7),(18). These studies stated that PCT levels were also high in non infected neonates with conditions like perinatal asphyxia, intracranial haemorrhage and resuscitation measures which affected the specificity of PCT. However, the protocol of this study implemented exclusive criteria that omit the influence of non-infectious confounders. PCT which is also an acute phase reactant rises as early as four hours after infection or exposure to bacterial toxins, peaks at 6-8 hours and the levels correlate with the level of severity of infection (19).

In this study, it was also noted that high mortality was seen among confirmed sepsis group. All babies who died also had high PCT level (more than 2ng/mL). Similar studies by Brunkhorst FM et al., and Jensen JU et al., have demonstrated higher PCT values related to septic shock and death (20),(21). The present study confirmed the findings of other investigators that PCT was more sensitive than CRP in detecting NS, as the PCT level rose earlier than the CRP level during sepsis.

Limitation(s)

The limitation of the study is that sampling time did not consider timing of onset of sepsis and PCT and CRP was not repeated due to financial constrain.
 
 
Conclusion

Based on the present study results, PCT is a better septic marker than CRP in relation to sensitivity, specificity and accuracy. It correlates well with the gold standard test, i.e., blood culture. CRP can be used as a good marker for diagnosis of sepsis, especially in poor resources settings as it is easily measurable and more affordable.
 
vioft2nnt8|20168B9C207A|jcdrorgin_ijnmr_frontend|Articles|article_references|0xe3ff9b2f09000000c001000001000a00
REFERENCES
1.
Bang AT, Bang RA, Bactule SB, Reddy HM, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: Field trial in rural India. Lancet. 1999;354:1955-61.   [Google Scholar]
2.
Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 1997;24:01-21.   [Google Scholar]
3.
Shankar MJ, Aggarwal R, Deorari AK, Paul VK. Symposium on AIIMS protocol in Neonatology- III. Indian J Paediatr. 2008;75:261-66.   [Google Scholar]
4.
Okascharoen C, Sirinavin S, Thakkinstian A, Kitayaporn D, Supapanachart S. A bedside prediction scoring model for late-onset neonatal sepsis. J Perinatal. 2005;25:778-83.   [Google Scholar]
5.
Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed. 2006;91:F208-12.   [Google Scholar]
6.
Hisamuddin E, Hisam A, Wahid S, Raza G. Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pak J Med Sci. 2015;31(3):527-31.   [Google Scholar]
7.
Thayi S, Ramesh TV. Comparative study of C-reactive protein versus procalcitonin as an early marker of neonatal sepsis. Int J Contemp Pediatr. 2016;3:878-81.   [Google Scholar]
8.
Sucilathangam G, Amuthavalli K, Velvizhi G, Ashihabegum MA, Jeyamurugan T, Palaniappan N. Early diagnostic markers for neonatal sepsis: Comparing Procalcitonin (PCT) and C-Reactive Protein (CRP). J Clin Diag Res. 2012;6:627-31.   [Google Scholar]
9.
Naher BS, Mannan MA, Noor K, Shahiddullah M. Role of serum procalcitonin and C-reactive protein in the diagnosis of neonatal sepsis. Bangladesh Med Res Counc Bull. 2011;37(2):40-46.   [Google Scholar]
10.
Bala Y, Randhawa VS, Kaur R, Saili A, Chitkara S. Role of procalcitonin in diagnosis of early onset neonatal sepsis in a north Indian tertiary care centre. Int J Curr Microbiol App Sci. 2018;7(08):490-98.   [Google Scholar]
11.
Ghosh P, Misra RN, Paul R. Neonatal sepsis-culture positive sepsis vs clinical sepsis. International J Current Res. 2016;8(5):31234-37.   [Google Scholar]
12.
Park IH, Lee SH, Yu ST, Oh YK. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Paed. 2014;57(10):451-56.   [Google Scholar]
13.
Jafar H, Agarwal J, Kalyan RK, Radera S, Verma S, Kumar M, Tripathi S. Role of serum procalcitonin as a marker for diagnosing neonatal sepsis. Int J Contemp Pediatr. 2019;6:1991-97.   [Google Scholar]
14.
Kumar R, Kumari A, Kumari A, Verma N. Evaluation of perinatal factors in neonatal sepsis at tertiary centre. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2017;6(11):4981-85.   [Google Scholar]
15.
Hasan F, Khan SA, Maharoof MK, Muhammed N. Role of procalcitonin in early diagnosis of neonatal sepsis. Int J Contemp Pediatr. 2017;4:383-89.   [Google Scholar]
16.
Dollner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: Comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clinic Epidemiol. 2001;54:251-57.   [Google Scholar]
17.
Hofer N, Muller W, Resch B. (2013). The role of C-reactive protein in the diagnosis of neonatal sepsis. Available from: https://www. intechopen.com/books/neonatal-bacterial-infection/the-role-of-c-reactive-protein-in-the-diagnosis-of-neonatal-sepsis   [Google Scholar]
18.
Janota J, Stranak Z, Belohlavkova S, Mudra K, Simak J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur Clin Invest. 2001;31:978-83.   [Google Scholar]
19.
Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013;28(3):285-91.   [Google Scholar]
20.
Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002;8(2):93-100.   [Google Scholar]
21.
Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, et al. The Procalcitonin And Survival Study (PASS)- A randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. BMJ Infectious Diseases. 2008;8:91.   [Google Scholar]
 
TABLES AND FIGURES
[Table/Fig-1] [Table/Fig-2] [Table/Fig-3] [Table/Fig-4] [Table/Fig-5]
[Table/Fig-6] [Table/Fig-7] [Table/Fig-8]
 
 
 

In This Article

  • Abstract
  • Material and Methods
  • Results
  • Discussion
  • Conclusion
  • References

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • How to Cite
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  | 
IJNMR Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
© 2023 INDIAN JOURNAL OF NEONATAL MEDICINE & RESEARCH (IJNMR), ISSN : 2277-8527.
EDITORIAL OFFICE : 3rd Floor, Hemraj Jain Building, 4352 Pahari Dhiraj, Delhi, India 110006,Phone : 01123848553

* This Journal is owned and run by medical professionals *